LakeShore Biopharma (LSB) said Tuesday the Nasdaq Stock Market notified the company Oct. 21 that it was in compliance with the exchange's minimum bid price requirement for continued listing.
The company regained compliance after the closing bid price of its shares was at $1 each or higher for 11 consecutive business days through Oct. 18.
LakeShore shares were up 3.5% in recent trading.
Price: 2.97, Change: +0.10, Percent Change: +3.48
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.